Skip to content

The effect mobile application on blood sugar control and lifestyle diabetics

The effect of the telenursing using a mobile application on the lifestyle and glycosylated hemoglobin in patients with type 2 diabetes referred to diabetes center of Motahari clinic 1395

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016101630320N1
Enrollment
132
Registered
2016-11-12
Start date
2016-11-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus type II. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: In the experimental group using the software that is installed on their mobile phone, learning about diabetes, exercise, nutrition, foot care, diabetes and prevent complications they a
Lifestyle
In the experimental group using the software that is installed on their mobile phone, learning about diabetes, exercise, nutrition, foot care, diabetes and prevent complications they are given. Patien

Sponsors

Vice chancellor for research, Shiraz University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Diabetes Mellitus Type II and requires daily injections of insulin (based on the detection endocrinologist, citing patient record); The minimum literacy education (the educated are not medical science.); Traverse at least one year of their infection diagnosed diabetes (condition is stabilized); Having the ability to understand content based on investigator judgment; Having to know the Persian languag; Non- pregnant women; Consent to participate in the study; Having a mobile phone with the ability to install applications; The ability to work with Mobile App; Lack of immune deficiency diseases; No underlying chronic disease; Exclusion criteria: Not wanting to continue participating in study; Failure to submit blood sugar for a week; Hospitalization

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Glycosylated hemoglobin. Timepoint: Before intervention, three months after intervention. Method of measurement: Blood test.;Life style. Timepoint: Before intervention, three months after intervention. Method of measurement: Life style Questionnaire.

Secondary

MeasureTime frame
Body mass index. Timepoint: Before intervention, three months after intervention. Method of measurement: Weight (kg)/ height (m)2.;Blood Pressure. Timepoint: Before intervention, three months after intervention. Method of measurement: Sphygmomanometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Zahra Molazem

Shiraz University of Medical Science,Shiraz Hazrate Fatemeh Nursing and Midwifery college

molazem@sums.ac.ir+98 71 3647 4254

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026